$ZOM
Zomedica Corp. Stock $zom

$zom Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000165495421012079 Filed on November 12, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q4
Revenue	$4.081M	$22.51K	$0.00
YoY Change
Cost Of Revenue	$1.020M	$17.90K
YoY Change
Gross Profit	$3.061M	$4.615K
YoY Change
Gross Profit Margin	75.01%	20.5%
Selling, General & Admin	$8.155M	$6.124M	$3.171M
YoY Change	157.21%	166.47%	70.13%
% of Gross Profit	266.41%	132706.0%
Research & Development	$664.9K	$288.5K
YoY Change		-89.32%
% of Gross Profit	21.72%	6250.34%
Depreciation & Amortization	$828.2K	$60.45K	$119.7K
YoY Change	592.09%	-22.7%	-41.25%
% of Gross Profit	27.06%	1309.75%
Operating Expenses	$8.820M	$6.413M	$4.128M
YoY Change	113.64%	28.25%	44.49%
Operating Profit	-$5.759M	-$6.408M
YoY Change		28.15%
Interest Expense	$71.32K	$0.00	$5.350K
YoY Change	1233.08%		2447.62%
% of Operating Profit
Other Income/Expense, Net	$43.38K	$600.00	$1.140K
YoY Change	3705.26%	-69.39%
Pretax Income	-$5.623M	-$6.346M	-$4.173M
YoY Change	34.74%	27.42%	46.07%
Income Tax	-$2.333M	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.290M	-$6.346M	-$4.173M
YoY Change	-21.16%	27.42%	46.07%
Net Earnings / Revenue	-80.62%	-28185.52%
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share	-$3.357K	-$6.485K	-$7.148K
COMMON SHARES
Basic Shares Outstanding	979.9M shares	978.5M shares	564.1M
Diluted Shares Outstanding		978.5M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$195.0M	$271.4M	$61.99M
YoY Change	214.48%	421.62%	12041.19%
Cash & Equivalents	$195.0M	$271.4M	$61.99M
Short-Term Investments
Other Short-Term Assets	$1.842M	$1.634M	$727.8K
YoY Change	153.06%	75.23%	-40.76%
Inventory	$2.848M	$1.424M	$0.00
Prepaid Expenses		$1.634M	$1.728M
Receivables	$765.5K	$6.938K	$0.00
Other Receivables	$0.00	$258.4K	$146.2K
Total Short-Term Assets	$200.4M	$274.7M	$63.87M
YoY Change	213.79%	417.45%	3434.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.130M	$706.3K	$583.0K
YoY Change	93.82%	-2.0%	-20.04%
Goodwill	$43.29M		$0.00
YoY Change
Intangibles	$33.18M	$474.0K	$362.7K
YoY Change	9047.89%	16.0%	-33.26%
Long-Term Investments
YoY Change
Other Assets	$265.0K	$168.0K	$1.000M
YoY Change	-73.5%	-83.2%
Total Long-Term Assets	$79.99M	$2.768M	$2.278M
YoY Change	3411.07%	-21.14%	-4.12%
TOTAL ASSETS
Total Short-Term Assets	$200.4M	$274.7M	$63.87M
Total Long-Term Assets	$79.99M	$2.768M	$2.278M
Total Assets	$280.4M	$277.5M	$66.14M
YoY Change	323.92%	390.25%	1481.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.225M	$4.465M
YoY Change		243.35%
Accrued Expenses	$239.9K
YoY Change
Deferred Revenue	$198.0K		$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$527.4K
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$0.00	$0.00	$527.4K
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$4.340M	$4.872M	$2.029M
YoY Change	113.92%	135.34%	-2.81%
LONG-TERM LIABILITIES
Long-Term Debt	$964.2K	$1.070M	$0.00
YoY Change		-7.33%
Other Long-Term Liabilities	$361.0K	$1.070M	$0.00
YoY Change
Total Long-Term Liabilities	$361.0K	$1.019M	$1.088M
YoY Change	-66.82%	-11.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.340M	$4.872M	$2.029M
Total Long-Term Liabilities	$361.0K	$1.019M	$1.088M
Total Liabilities	$9.514M	$5.942M	$3.117M
YoY Change	205.25%	84.27%	49.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$119.4M	-$116.1M	-$68.97M
YoY Change	73.11%	79.18%	32.49%
Common Stock	$390.3M	$387.7M	$119.6M
YoY Change	226.38%	264.98%	183.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$270.9M	$271.6M	$51.07M
YoY Change
Total Liabilities & Shareholders Equity	$280.4M	$277.5M	$66.14M
YoY Change	323.92%	390.25%	1481.26%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q4
OPERATING ACTIVITIES
Net Income	-$3.290M	-$6.346M	-$4.173M
YoY Change	-21.16%	27.42%	46.07%
Depreciation, Depletion And Amortization	$828.2K	$60.45K	$119.7K
YoY Change	592.09%	-22.7%	-41.25%
Cash From Operating Activities	-$4.901M	-$4.998M	-$2.683M
YoY Change	82.68%	-11.74%	43.78%
INVESTING ACTIVITIES
Capital Expenditures	-$183.7K	-$201.2K	-$16.18K
YoY Change	1035.04%	-32917.29%	-45.94%
Acquisitions
YoY Change
Other Investing Activities	-$71.40M	$150.00	$15.00K
YoY Change	-476096.13%
Cash From Investing Activities	-$71.58M	-$201.0K	-$1.180K
YoY Change	6066261.86%	32692.82%	-96.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	23.93K	400.2K	12.64M
YoY Change	-99.81%	-98.6%	-15709.04%
NET CHANGE
Cash From Operating Activities	-4.901M	-4.998M	-2.683M
Cash From Investing Activities	-71.58M	-201.0K	-1.180K
Cash From Financing Activities	23.93K	400.2K	12.64M
Net Change In Cash	-76.46M	-4.799M	9.959M
YoY Change	-867.75%	-120.93%	-603.73%
FREE CASH FLOW
Cash From Operating Activities	-$4.901M	-$4.998M	-$2.683M
Capital Expenditures	-$183.7K	-$201.2K	-$16.18K
Free Cash Flow	-$4.718M	-$4.797M	-$2.667M
YoY Change	76.9%	-15.3%	45.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	979738168	shares
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12738582	USD
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	642036228	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	380928831	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6938	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2021Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	258359	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	146207	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	274734109	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1633846	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1727814	USD
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	979894668	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	271411043	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61991703	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	1423923	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	63865724	USD
CY2021Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	168020	USD
CY2020Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	13924	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	706266	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	583007	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1419790	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1318716	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	473966	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	362663	USD
CY2021Q3	us-gaap	Assets Assets	277502151	USD
CY2020Q4	us-gaap	Assets Assets	66144034	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4464874	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1248628	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	527360	USD
CY2021Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	407278	USD
CY2020Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	252788	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4872152	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2028776	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1069687	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1087998	USD
CY2021Q3	us-gaap	Liabilities Liabilities	5941839	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	104783612	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14792276	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116101406	USD
CY2020Q4	us-gaap	Liabilities Liabilities	3116774	USD
CY2021Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	20	shares
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68969625	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	271560312	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	51065863	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	277502151	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66144034	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	22514	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	52331	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	17899	USD
CY2021Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	59433	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	4615	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	0	USD
	us-gaap	Gross Profit GrossProfit	-7102	USD
	us-gaap	Gross Profit GrossProfit	0	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	288453	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	12	shares
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2702103	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1008083	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	11961397	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7205674	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6124382	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2298330	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14593952	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5430812	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6408220	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5000433	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15609137	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12636486	USD
CY2021Q3	us-gaap	Interest Income Operating InterestIncomeOperating	94302	USD
CY2020Q3	us-gaap	Interest Income Operating InterestIncomeOperating	21238	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	261556	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-6345687	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	21566	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4979975	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15093178	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	6054	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12738582	USD
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	978494076	shares
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	550541878	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	948664410	shares
	us-gaap	Interest Expense InterestExpense	732	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	269707	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	51065863	USD
	zom	Stock Issuance For Financing Amount StockIssuanceForFinancingAmount	199525000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6345687	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	291314002	shares
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4979975	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15093178	USD
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	128931	USD
CY2020Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-533414	USD
CY2021Q3	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	0	USD
CY2020Q4	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	459600	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6732887	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-600	USD
CY2020Q3	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-1963	USD
	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-2481	USD
	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-7463	USD
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5609	USD
CY2020Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2743	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5731	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1462	USD
CY2020Q3	zom	Adjustments To Equity Warrant Issued AdjustmentsToEquityWarrantIssued	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4502597	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	478835	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	187969	USD
	zom	Noncash Rent Expense NoncashRentExpense	35838	USD
	zom	Noncash Rent Expense NoncashRentExpense	16051	USD
CY2020Q3	zom	Stock Issued From Exercise Of Warrants And Prefunded Warrants Amount StockIssuedFromExerciseOfWarrantsAndPrefundedWarrantsAmount	2329049	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4979975	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1875423	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	zom	Increase Decrease In Prepaid Expense And Deposits IncreaseDecreaseInPrepaidExpenseAndDeposits	-61004	USD
	zom	Increase Decrease In Prepaid Expense And Deposits IncreaseDecreaseInPrepaidExpenseAndDeposits	-1003091	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6938	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15093178	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12738582	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	478835	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-122972	USD
	zom	Stock Issued From Exercise Of Warrants And Prefunded Warrants Amount StockIssuedFromExerciseOfWarrantsAndPrefundedWarrantsAmount	12155409	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12738582	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	87958137	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-61651	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3216246	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-787124	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9373804	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	29578961	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	28532000	USD
CY2020Q3	zom	Stock Issuance Costs Amount StockIssuanceCostsAmount	-2268215	USD
	zom	Stock Issuance Costs Amount StockIssuanceCostsAmount	-14280914	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4502597	USD
	zom	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	32111537	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1768010	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	11961397	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15093178	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	271560312	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	276068013	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1437778	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	400208	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-6345687	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	271560312	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2095459	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	56496283	USD
	zom	Stock Issuance Costs Amount StockIssuanceCostsAmount	-5107615	USD
	zom	Adjustments To Equity Warrant Issued AdjustmentsToEquityWarrantIssued	0	USD
	us-gaap	Depreciation Depreciation	175168	USD
	us-gaap	Depreciation Depreciation	232475	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	136200	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	177873	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	247753	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	69834	USD
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	5323	USD
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	59097	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-533414	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13556283	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	225	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	5400	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	245560	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	96964	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	613	USD
	zom	Proceeds From Refund Of Prepaid Rent ProceedsFromRefundOfPrepaidRent	0	USD
	zom	Proceeds From Refund Of Prepaid Rent ProceedsFromRefundOfPrepaidRent	1002113	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-342299	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1006900	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	199525000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	56496283	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	32111537	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	12155409	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1768010	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	zom	Proceeds From Pending Warrant Exercises ProceedsFromPendingWarrantExercises	0	USD
	zom	Proceeds From Pending Warrant Exercises ProceedsFromPendingWarrantExercises	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	14269104	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5107615	USD
	zom	Proceeds For Government Loan ProceedsForGovernmentLoan	0	USD
	zom	Proceeds For Government Loan ProceedsForGovernmentLoan	527360	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	219135443	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64071437	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	209419340	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	51522054	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61991703	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	510586	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	271411043	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52032640	USD
	zom	Transfer Of Inventory Into Property And Equipment TransferOfInventoryIntoPropertyAndEquipment	451500	USD
	zom	Transfer Of Inventory Into Property And Equipment TransferOfInventoryIntoPropertyAndEquipment	0	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	11810	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
	zom	Account Receivable Recorded In Intercompany Account AccountReceivableRecordedInIntercompanyAccount	-990	USD
	zom	Account Receivable Recorded In Intercompany Account AccountReceivableRecordedInIntercompanyAccount	0	USD
	zom	Net Equity Effect Of Preferred Share Exchange NetEquityEffectOfPreferredShareExchange	-11961397	USD
	zom	Net Equity Effect Of Preferred Share Exchange NetEquityEffectOfPreferredShareExchange	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	651	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	228881	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	14347	USD
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Estimates and assumptions</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In preparing these financial statements, management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of uncertainty. We are not presently aware of any events or circumstances that would require us to update such estimates and assumptions or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur, and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.</p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Comparative figures</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior year amounts have been reclassified to conform to the current year presentation. The change in presentation had no effect on the reported results of operations. Adjustments have been made to the consolidated balance sheets and consolidated statements of loss and comprehensive loss for three and six months ended September 30, 2020. These changes in classification do not affect previously reported cash flows from operating activities in the consolidated statements of cash flows.</p>
CY2021Q3	us-gaap	Deposit Assets DepositAssets	1256094	USD
CY2020Q4	us-gaap	Deposit Assets DepositAssets	1469043	USD
CY2021Q3	us-gaap	Prepaid Advertising PrepaidAdvertising	64300	USD
CY2020Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	26330	USD
CY2021Q3	us-gaap	Prepaid Insurance PrepaidInsurance	380254	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	184154	USD
CY2021Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	101218	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	62211	USD
CY2021Q3	zom	Prepaid Expenses And Deposits PrepaidExpensesAndDeposits	1801866	USD
CY2020Q4	zom	Prepaid Expenses And Deposits PrepaidExpensesAndDeposits	1741738	USD
CY2021Q3	zom	Prepaid Expenses And Deposits Noncurrent PrepaidExpensesAndDepositsNoncurrent	168020	USD
CY2020Q4	zom	Prepaid Expenses And Deposits Noncurrent PrepaidExpensesAndDepositsNoncurrent	13924	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1512102	USD
CY2021Q3	zom	Operating Lease Right Of Use Asset Cost OperatingLeaseRightOfUseAssetCost	1624103	USD
CY2020Q4	zom	Operating Lease Right Of Use Asset Cost OperatingLeaseRightOfUseAssetCost	1553611	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	326335	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	190135	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1290993	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	805836	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	707986	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	706266	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	583007	USD
CY2021Q3	us-gaap	Depreciation Depreciation	60445	USD
CY2020Q3	us-gaap	Depreciation Depreciation	78200	USD
	us-gaap	Depreciation Depreciation	175168	USD
	us-gaap	Depreciation Depreciation	232475	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	800301	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	552798	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	473966	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	362663	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46732	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	45399	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	136200	USD
CY2021Q3	zom	Operating Lease Right Of Use Asset Aggregate Lease Commitments OperatingLeaseRightOfUseAssetAggregateLeaseCommitments	1778798	USD
CY2020Q4	zom	Operating Lease Right Of Use Asset Aggregate Lease Commitments OperatingLeaseRightOfUseAssetAggregateLeaseCommitments	2067505	USD
CY2021Q3	zom	Operating Lease Right Of Use Asset Impact Of Present Value OperatingLeaseRightOfUseAssetImpactOfPresentValue	154695	USD
CY2020Q4	zom	Operating Lease Right Of Use Asset Impact Of Present Value OperatingLeaseRightOfUseAssetImpactOfPresentValue	513894	USD
	zom	Operating Lease Rightofuse Asset Interest OperatingLeaseRightofuseAssetInterest	-27901	USD
	zom	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	232214	USD
CY2020	zom	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	379043	USD
CY2020	zom	Operating Lease Rightofuse Asset Interest OperatingLeaseRightofuseAssetInterest	-144148	USD
CY2021Q3	zom	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	204313	USD
CY2020Q4	zom	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	234895	USD
	zom	Net Book Value NetBookValue	1419790	USD
CY2020	zom	Net Book Value NetBookValue	1318716	USD
	zom	Operating Lease Liability Additions OperatingLeaseLiabilityAdditions	1647449	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	356972	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	198385	USD
CY2020	zom	Operating Lease Liability Additions OperatingLeaseLiabilityAdditions	1553611	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2900000	shares
	zom	Operating Lease Liability Interest OperatingLeaseLiabilityInterest	27901	USD
CY2020	zom	Operating Lease Liability Interest OperatingLeaseLiabilityInterest	144147	USD
CY2021Q3	zom	Total Lease Liabilities TotalLeaseLiabilities	1476965	USD
CY2020Q4	zom	Total Lease Liabilities TotalLeaseLiabilities	1340786	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	407278	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	252788	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1069687	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1087998	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1476965	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1340786	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	112342	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	400133	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	461727	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	412137	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	475579	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	424501	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	489845	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	437236	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	40920	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	36526	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1580413	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1710533	USD
CY2020Q1	zom	Emergency Economic Relief EmergencyEconomicRelief	2000000000000.0	USD
CY2020Q1	zom	Temporarily Guarantee Loans Description TemporarilyGuaranteeLoansDescription	The Program provides for 100% federally guaranteed loans to small businesses to allow employers to keep workers employed and maintain payroll during the pandemic and economic downturn. Under the Program, qualified companies are eligible for a loan in an amount equal to the lesser of $10 million or 2.5x the business’s average monthly payroll
CY2020Q2	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	527360	USD
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	32038603	USD
CY2020Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	20833334	shares
CY2020Q1	zom	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	20833334	shares
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.20
CY2020Q1	zom	Class Of Warrant Or Right Issued During Period Value ClassOfWarrantOrRightIssuedDuringPeriodValue	794345	USD
CY2020Q1	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	348220	USD
CY2020Q2	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	582977	USD
CY2020Q2	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	1908202	USD
CY2020Q3	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	2268215	USD
CY2020Q2	zom	Stock Issued During Period Shares Exercise Of Warrants And Prefunded Warrants StockIssuedDuringPeriodSharesExerciseOfWarrantsAndPrefundedWarrants	12162492	shares
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	199525000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12100000	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1787175	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7017776	shares
CY2021Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	400208	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	515000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7571000	shares
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	187969	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	478835	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	39604515	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12100000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.86
	zom	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Including Deferred Issuances SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodIncludingDeferredIssuances	7017776	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.25
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1670000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	4034015	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.52
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	38982724	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.40
CY2021Q3	zom	Number Of Options Options Vested In Shares NumberOfOptionsOptionsVestedInShares	9152474	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.28
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	38982724	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9152474	shares
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	29830250	shares
CY2021Q1	zom	Volatility Volatility	1.17	pure
CY2021Q1	zom	Volatility Volatility	1.17	pure
CY2021Q1	zom	Volatility Volatility	1.17	pure
CY2021Q1	zom	Volatility Volatility	1.17	pure
CY2021Q1	zom	Risk Free Interest Rate RiskFreeInterestRate	0.0095	pure
CY2021Q1	zom	Risk Free Interest Rate RiskFreeInterestRate	0.0092	pure
CY2021Q1	zom	Risk Free Interest Rate RiskFreeInterestRate	0.0107	pure
CY2021Q1	zom	Risk Free Interest Rate RiskFreeInterestRate	0.0106	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q1	us-gaap	Share Price SharePrice	1.87
CY2021Q1	us-gaap	Share Price SharePrice	2.06
CY2021Q1	us-gaap	Share Price SharePrice	1.88
CY2021Q1	us-gaap	Share Price SharePrice	2.49
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.87
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	2.06
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.88
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	2.49
CY2021Q3	zom	Accounts Payable And Accrued Liabilities Due In3 To6 Months AccountsPayableAndAccruedLiabilitiesDueIn3To6Months	0	USD
CY2021Q3	zom	Accounts Payable And Accrued Liabilities Due In6 To9 Months AccountsPayableAndAccruedLiabilitiesDueIn6To9Months	0	USD
CY2021Q3	zom	Accounts Payable And Accrued Liabilities Due In9 To12 Months AccountsPayableAndAccruedLiabilitiesDueIn9To12Months	0	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	0	USD
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1068918	shares
	zom	Sub Total Warrent Exercised Shares SubTotalWarrentExercisedShares	359972750	shares
	zom	Sub Total Warrent Amount SubTotalWarrentAmount	56910269	USD
	zom	Common Stock Subscribed Amount CommonStockSubscribedAmount	-459600	USD
	zom	Total Warrant Execised TotalWarrantExecised	359972750	shares
	zom	Total Amount TotalAmount	56450669	USD
CY2021Q3	zom	Accounts Payable And Accrued Liabilities Due Less Than3 Months AccountsPayableAndAccruedLiabilitiesDueLessThan3Months	4464874	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	4464874	USD
CY2021Q3	zom	Operating Lease Liability Due Less Than3 Months OperatingLeaseLiabilityDueLessThan3Months	112343	USD
CY2021Q3	zom	Operating Lease Liability Due In3 To6 Months OperatingLeaseLiabilityDueIn3To6Months	114589	USD
CY2021Q3	zom	Operating Lease Liability Due In6 To9 Months OperatingLeaseLiabilityDueIn6To9Months	115713	USD
CY2021Q3	zom	Operating Lease Liability Due In9 To12 Months OperatingLeaseLiabilityDueIn9To12Months	115713	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1018607	USD
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	1476965	USD
CY2021Q3	zom	Liabilities Due In Less Than3 Months LiabilitiesDueInLessThan3Months	4577217	USD
CY2021Q3	zom	Liabilities Due In3 To6 Months LiabilitiesDueIn3To6Months	114589	USD
CY2021Q3	zom	Liabilities Due In6 To9 Months LiabilitiesDueIn6To9Months	115713	USD
CY2021Q3	zom	Liabilities Due In9 To12 Months LiabilitiesDueIn9To12Months	115713	USD
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1018607	USD
CY2021Q3	us-gaap	Liabilities Liabilities	5941839	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1248628	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-6345687	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1318716	USD
CY2021Q3	zom	Property Plant And Equipment Including Leased Assets PropertyPlantAndEquipmentIncludingLeasedAssets	2126056	USD
CY2020Q4	zom	Property Plant And Equipment Including Leased Assets PropertyPlantAndEquipmentIncludingLeasedAssets	1901723	USD
CY2020Q4	zom	Accounts Payable And Accrued Liabilities Due In3 To6 Months AccountsPayableAndAccruedLiabilitiesDueIn3To6Months	0	USD
CY2020Q4	zom	Accounts Payable And Accrued Liabilities Due In6 To9 Months AccountsPayableAndAccruedLiabilitiesDueIn6To9Months	0	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	0	USD
CY2020Q4	zom	Accounts Payable And Accrued Liabilities Due Less Than3 Months AccountsPayableAndAccruedLiabilitiesDueLessThan3Months	1248628	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	527360	USD
CY2020Q4	zom	Longterm Debt Due In3 To6 Months LongtermDebtDueIn3To6Months	0	USD
CY2020Q4	zom	Longterm Debt Due In6 To9 Months LongtermDebtDueIn6To9Months	0	USD
CY2020Q4	zom	Longterm Debt Due In9 To12 Months LongtermDebtDueIn9To12Months	0	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	zom	Longterm Debt Due Less Than3 Months LongtermDebtDueLessThan3Months	527360	USD
CY2020Q4	zom	Operating Lease Liability Due Less Than3 Months OperatingLeaseLiabilityDueLessThan3Months	59662	USD
CY2020Q4	zom	Operating Lease Liability Due In3 To6 Months OperatingLeaseLiabilityDueIn3To6Months	62463	USD
CY2020Q4	zom	Operating Lease Liability Due In6 To9 Months OperatingLeaseLiabilityDueIn6To9Months	64356	USD
CY2020Q4	zom	Operating Lease Liability Due In9 To12 Months OperatingLeaseLiabilityDueIn9To12Months	66307	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1087998	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1340786	USD
CY2020Q4	zom	Liabilities Due In Less Than3 Months LiabilitiesDueInLessThan3Months	1835650	USD
CY2020Q4	zom	Liabilities Due In3 To6 Months LiabilitiesDueIn3To6Months	62463	USD
CY2020Q4	zom	Liabilities Due In6 To9 Months LiabilitiesDueIn6To9Months	64356	USD
CY2020Q4	zom	Liabilities Due In9 To12 Months LiabilitiesDueIn9To12Months	66307	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1087998	USD
CY2020Q4	us-gaap	Liabilities Liabilities	3116774	USD
CY2021Q3	us-gaap	Assets Assets	277502151	USD
CY2020Q4	us-gaap	Assets Assets	66144034	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	706266	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	583007	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1419790	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-4979975	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15093178	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12738582	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4979975	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47131781	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12738582	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6345687	USD
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	32038603	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	978494076	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	550541878	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	948664410	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	291314002	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	978494076	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	550541878	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	948664410	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	291314002	shares
CY2021Q3	zom	Loss Per Share Basic And Diluted In Dollars Per Share LossPerShareBasicAndDilutedInDollarsPerShare	-0.01
CY2020Q3	zom	Loss Per Share Basic And Diluted In Dollars Per Share LossPerShareBasicAndDilutedInDollarsPerShare	-0.01
	zom	Loss Per Share Basic And Diluted In Dollars Per Share LossPerShareBasicAndDilutedInDollarsPerShare	-0.05
	zom	Loss Per Share Basic And Diluted In Dollars Per Share LossPerShareBasicAndDilutedInDollarsPerShare	-0.04

Files In Submission

Name	View Source	Status
0001654954-21-012079-index-headers.html	Edgar Link	pending
0001654954-21-012079-index.html	Edgar Link	pending
0001654954-21-012079.txt	Edgar Link	pending
0001654954-21-012079-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
greh_10q.htm	Edgar Link	pending
greh_10q_htm.xml	Edgar Link	completed
greh_ex101img1.jpg	Edgar Link	pending
greh_ex101img2.jpg	Edgar Link	pending
greh_ex102.htm	Edgar Link	pending
greh_ex103.htm	Edgar Link	pending
greh_ex103img1.jpg	Edgar Link	pending
greh_ex103img10.jpg	Edgar Link	pending
greh_ex103img11.jpg	Edgar Link	pending
greh_ex103img12.jpg	Edgar Link	pending
greh_ex103img13.jpg	Edgar Link	pending
greh_ex103img14.jpg	Edgar Link	pending
greh_ex103img15.jpg	Edgar Link	pending
greh_ex103img16.jpg	Edgar Link	pending
greh_ex103img2.jpg	Edgar Link	pending
greh_ex103img3.jpg	Edgar Link	pending
greh_ex103img4.jpg	Edgar Link	pending
greh_ex103img5.jpg	Edgar Link	pending
greh_ex103img6.jpg	Edgar Link	pending
greh_ex103img7.jpg	Edgar Link	pending
greh_ex103img8.jpg	Edgar Link	pending
greh_ex103img9.jpg	Edgar Link	pending
greh_ex311.htm	Edgar Link	pending
greh_ex312.htm	Edgar Link	pending
greh_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zom-20210930.xsd	Edgar Link	pending
zom-20210930_cal.xml	Edgar Link	unprocessable
zom-20210930_def.xml	Edgar Link	unprocessable
zom-20210930_lab.xml	Edgar Link	unprocessable
zom-20210930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZOM
Zomedica Corp. Stock $zom

2021 Q4 Form 10-Q Financial Statement

#000165495421012079 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZOM Zomedica Corp. Stock $zom

2021 Q4 Form 10-Q Financial Statement

#000165495421012079 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZOM
Zomedica Corp. Stock $zom